Price target
1.460.00 0.00%
The 3 analysts offering 1 year price forecasts for DPHARMA have a max estimate of — and a min estimate of —.
Analyst rating
Based on 3 analysts giving stock ratings to DPHARMA in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
In the next quarter DUOPHARMA BIOTECH BERHAD revenue is expected to reach 0 MYR. Check out DUOPHARMA BIOTECH BERHAD revenue and earnings and make informed decisions.
According to analysts, DPHARMA price target is 1.46 MYR with a max estimate of 1.50 MYR and a min estimate of 1.41 MYR. Check if this forecast comes true in a year, meanwhile keep track of the current situation with DPHARMA news and stock market news.
We've gathered opinions of 3 analysts rating DPHARMA stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.